Skip to content
Independent analysis of NHS open data
PharmaInsight

Doravirine/lamivudine/tenofovir disoproxil vs Entecavir

National NHS prescribing compared (Prescription Cost Analysis)
Data updated March 2026

Entecavir was dispensed 279.0× as often as Doravirine/lamivudine/tenofovir disoproxil in March 2026 — 279 items versus 1 in England.

1items

Doravirine/lamivudine/tenofovir disoproxil · March 2026

NHSBSA Prescription Cost Analysis

279items

Entecavir · March 2026

NHSBSA Prescription Cost Analysis

Figure 1. Doravirine/lamivudine/tenofovir disoproxil versus Entecavir: national items dispensed by month

▬ Doravirine/lamivudine/tenofovir disoproxil   ·   ╌ Entecavir

0 150 300 May 2021 Dec 2021 Aug 2022 Jan 2024 Apr 2024 Apr 2025 Mar 2026 Entecavir 1 May 2021: 2 Sep 2021: 1 Dec 2021: 1 Jan 2022: 2 Aug 2022: 2 Oct 2022: 2 Jan 2024: 1 Mar 2024: 1 Apr 2024: 1 Aug 2024: 1 Apr 2025: 1 May 2025: 1 Oct 2025: 1 Mar 2026: 1

Source: NHSBSA Prescription Cost Analysis, to March 2026

Doravirine/lamivudine/tenofovir disoproxil versus Entecavir, March 2026
Measure Doravirine/lamivudine/tenofovir disoproxil Entecavir
Items, March 2026 1 279
Items, last 12 months 15 3,325
Net ingredient cost, March 2026 £579 £138,668

See the full profile for Doravirine/lamivudine/tenofovir disoproxil or Entecavir.